The Role of Phototherapy in Inflammatory Skin Disease
The Dermatology Digest
AUGUST 4, 2023
1 Explanations for the decline included poor compliance, poor reimbursement, fear of skin cancer, and the promise of newer therapies, said Dr. Richard. Adalimumab (Humira, Abbvie) was approved in 2005 for psoriatic arthritis and in 2008 for psoriasis. It’s a great adjunct therapy. It has a great [safety and efficacy] profile.
Let's personalize your content